Description

Tirzepatide – Research Grade Peptide (Dual GIP/GLP-1 Analog)

Description
Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist analog designed specifically for controlled laboratory and in-vitro research. Its unique dual-pathway structure makes it highly valuable in studies focused on metabolic regulation, receptor activity, and peptide signaling. With exceptional purity and stability, Tirzepatide provides reliable performance for advanced scientific exploration.

Key Features

High-purity peptide (≥98% purity verified by HPLC)
Dual GIP/GLP-1 receptor agonist analog
Lyophilized for extended stability and flexible laboratory handling
Ideal for cellular, biochemical, and receptor-binding research
Produced in a GMP-compliant facility with meticulous quality control

Molecular Details

Class: Dual GIP/GLP-1 receptor agonist analog
Sequence: Tyr-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Asn-Gly-Gly-Pro-Ile-Ser-Lys-Lys-Lys-Lys-Lys-Lys
Form: Lyophilized powder
Molecular Weight: ~4813.5 g/mol
Solubility: Soluble in bacteriostatic water for lab preparation
Storage: Refrigerate at 2–8°C; for long-term storage, freeze at -20°C

Research Applications
Tirzepatide is commonly explored in studies involving:

Dual-pathway metabolic modeling
GIP and GLP-1 receptor engagement
In-vitro metabolic and appetite-related signaling
Peptide-stability research
Cellular energy-balance pathways

Packaging
Each vial contains precision-measured, research-grade Tirzepatide, lyophilized and sealed under sterile, nitrogen-flushed conditions to maintain stability and integrity during storage and transport.

Important Notice (FDA Compliance)

Tirzepatide is sold strictly for laboratory research purposes only.
Not for human use. Not for consumption, injection, or therapeutic application.
By purchasing this product, you agree to use it solely within controlled research environments.